Who is sponsoring NCT05811780?

NCT05811780 is sponsored by University Hospital Freiburg.

What condition does NCT05811780 study?

NCT05811780 studies Medical Condition Requiring Extracorporeal Organ Support.

Is NCT05811780 still recruiting?

NCT05811780 is currently recruiting now. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT05811780

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry

Recruiting now Last updated 13 April 2023

What this trial tests

trial in Medical Condition Requiring Extracorporeal Organ Support in 1,500 participants. Currently enrolling.

Timeline

29 April 2014

Primary endpoint
31 December 2030

31 December 2035

Quick facts

Lead sponsor	University Hospital Freiburg
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,500
Start date	29 April 2014
Primary completion	31 December 2030
Estimated completion	31 December 2035
Sites	1 location across Germany

Conditions studied

Medical Condition Requiring Extracorporeal Organ Support — all drugs for Medical Condition Requiring Extracorporeal Organ Support →

Sponsor

University Hospital Freiburg

Who can join

Eligibility, any sex, with Medical Condition Requiring Extracorporeal Organ Support. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early Albumin Administration in Veno-Arterial Extracorporeal Membrane Oxygenation.
Wengenmayer T, Hirth ML, Jäckel M, Bemtgen X, et al · · 2025 · cited 1× · PMID 39713990 · DOI 10.1111/aor.14934

Verify or expand the search:

Other University Hospital Freiburg trials

Trials by the same sponsor.

NCT07359313 — Incidence of Colon Ischemia in Patients After Cardiopulmonary Resuscitation (CPR) · NA · not yet recruiting
NCT07082322 — European Prospective Bloodstream Infection Cohort · not yet recruiting
NCT06156644 — Pulsed-Field-Ablation to Treat Atrial fiBRillation With a novEl multimodalIty Generator · NA · not yet recruiting
NCT06576934 — Early TIPS in Patients With Liver Cirrhosis and Ascites · NA · recruiting
NCT06711731 — The Freiburg Registry on SpontanEous IntercrAnial Hypotension (SIH) & Post-duraL Puncture Headache (PDPH) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05811780 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Freiburg
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05811780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing